Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Pulse Biosciences, Inc. (PLSE)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 4.1 | 0.7 | | | | | | |
Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -519.2% | -393.2% | -211.8% | -235.3% | 0.0% | -102.9% | -133.9% | |
ROIC (including intangibles) | -394.1% | -332.0% | -228.5% | -148.8% | 0.0% | -57.6% | -40.8% | -27.5% |
ROE | 2582.6% | -176.6% | -218.2% | -149.6% | 0.0% | -55.6% | -37.6% | -20.6% |
ROA | -74.5% | -116.2% | -121.0% | -109.7% | 0.0% | -51.3% | -36.2% | -19.6% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 15.7 | | | | 0.0 | 0.0 | 0.0 |
Days payables outstanding | 48.1 | 538.6 | | 1,194.2 | 773.8 | 356.8 | 193.5 | 239.1 |
Days inventory outstanding | | 1,080.2 | | | | | | |
Cash conversion cycle | -48.1 | 557.3 | | | | -356.8 | -193.5 | -239.1 |
|